Casneuf, Tineke ; Xu, Xu Steven ; Adams, Homer C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728278/.  , 2017

McCudden, Christopher ; Axel, Amy E ; Slaets, Dominique...
McCudden , C , Axel , A E , Slaets , D , Dejoie , T , Clemens , P , Frans , S , Bald , J , Plesner , T , Jacobs , J F M , van de Donk , N W C J , Moreau , P , Schecter , J M , Ahmadi , T & Sasser , A K 2017 , ' Response to : Interference of daratumumab on the serum protein electrophoresis ' , Clinical Chemistry and Laboratory Medicine , vol. 55 , no. 2 , pp. e29-e30 . https://doi.org/10.1515/cclm-2016-1026.  , 2017

Casneuf, Tineke ; Axel, Amy E ; King, Peter...
info:eu-repo/semantics/altIdentifier/doi/10.2147/BCTT.S92414.  , 2016

McCudden, Christopher ; Axel, Amy E ; Slaets, Dominique...
McCudden , C , Axel , A E , Slaets , D , Dejoie , T , Clemens , P L , Frans , S , Bald , J , Plesner , T , Jacobs , J F M , van de Donk , N W C J , Moreau , P , Schecter , J M , Ahmadi , T & Sasser , A K 2016 , ' Monitoring multiple myeloma patients treated with daratumumab : teasing out monoclonal antibody interference ' , Clinical Chemistry and Laboratory Medicine , vol. 54 , no. 6 , pp. 1095-1104 . https://doi.org/10.1515/cclm-2015-1031.  , 2016

Verkleij, Christie P. M ; Broekmans, Marloes E. C ; van Duin, Mark...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095149/.  , 2021

Verkleij, Christie P. M ; Broekmans, Marloes E. C ; van Duin, Mark...
Verkleij , C P M , Broekmans , M E C , van Duin , M , Frerichs , K A , Kuiper , R , de Jonge , A V , Kaiser , M , Morgan , G , Axel , A , Boominathan , R , Sendecki , J , Wong , A , Verona , R I , Sonneveld , P , Zweegman , S , Adams , H C , Mutis , T & van de Donk , N W C J 2021 , ' Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma ' , Blood , vol. 5 , no. 8 , pp. 2196-2215 . https://doi.org/10.1182/BLOODADVANCES.2020003805.  , 2021

Frerichs, Kristine A ; Broekmans, Marloes E. C ; Marin Soto, Jhon A...
Frerichs , K A , Broekmans , M E C , Marin Soto , J A , van Kessel , B , Heymans , M W , Holthof , L C , Verkleij , C P M , Boominathan , R , Vaidya , B , Sendecki , J , Axel , A , Gaudet , F , Pillarisetti , K , Zweegman , S , Adams , H C , Mutis , T , van de Donk , N W C J & van de Donk , N W C J 2020 , ' Preclinical Activity of JNJ-7957, a Novel BCMA ×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab ' , Clinical cancer research : an official journal of the American Association for Cancer Research , vol. 26 , no. 9 , pp. 2203-2215 . https://doi.org/10.1158/1078-0432.CCR-19-2299.  , 2020